“MOgene is continually striving to become a one stop shop for genomics services,” said Shaukat Rangwala, senior vice president, MOgene LC. “Expanding our service offerings allows us to partner with our customers and provide high quality and cost effective research solutions.”
The PacBio RS II sequencer has the ability to sequence single molecule with 20kb plus read lengths. This process allows for a better de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms in important gene families, and find novel genes; targeted sequencing to more comprehensively characterize genetic variations; and DNA base modification identification to help characterize epigenetic regulation.
The St. Louis genomics company has a CLIA-certified lab that offers world class genomic services including Real Time PCR, RNA/DNA Isolation, Agilent-certified microarray services, Sequence Capture using Agilent SureSelect and NimbleGen SeqCap, targeted enrichment using Fluidigm Access array, NextGen sequencing services MiSeq, NextSeq & HiSeq Platform, as well as complete bioinformatics from experimental design to publication ready analysis.
MOgene continues to expand its services to their customer base by recently including CLIA-certified, Agilent and Illumina certification.
About MOgene LCMOgene, a Limited Liability Company has been in operations since February 2004. The company has established solid reputation as a global genomics service provider to academic, government and industrial research groups and institutions. MOgene offers nucleic acid isolation, library preparation, microarrays, Real-Time PCR, NextGen sequencing, sequence capture and bioinformatics. MOgene is also CLIA certified. www.mogene.com.
About Pacific BiosciencesPacific Biosciences of California, Inc. (NASDAQ:PACB) offers sequencing systems to help scientists resolve genetically complex problems. Based on its novel Single Molecule, Real-Time (SMRT®) Technology, Pacific Biosciences’ products enable: de novo genome assembly to finish genomes in order to more fully identify, annotate and decipher genomic structures; full-length transcript analysis to improve annotations in reference genomes, characterize alternatively spliced isoforms in important gene families, and find novel genes; targeted sequencing to more comprehensively characterize genetic variations; and DNA base modification identification to help characterize epigenetic regulation and DNA damage. Pacific Biosciences’ technology provides the industry’s highest consensus accuracy over the longest read lengths in combination with the ability to detect real-time kinetic information. More information is available at www.pacb.com.
About BRDG Park at the Danforth CenterBio Research & Development Growth (BRDG) Park at the Danforth Plant Science Center helps life science companies bridge research, resources and relationships to achieve commercial success. In addition to providing world-class wet laboratories, office space and a prominent incubator, BRDG Park’s location on the Danforth Center’s campus facilitates access to the intellectual capital of top scientists, as well as to greenhouses, growth chambers, microscopy and proteomics facilities and other vital resources. Located in suburban St. Louis County, Missouri, BRDG Park is being developed by Wexford Science +Technology LLC, a BioMed Realty Company, a development company led by a seasoned team of real estate, finance and engineering experts specializing in major university facilities and science research parks nationwide. More information is available at www.BRDG-Park.com.
RSS